Baba Ramdev To Launch Divya Coronil Tablet For Covid-19 Today
Share on social media

Last Updated on June 23, 2020 by admin

Divya Coronil Tablet Covid-19 Launch: Yoga guru Baba Ramdev will launch a medicine to treat Covid-19 today. The results of the clinical trial of Patanjali Ayurveda drug ‘Divya Coronil Tablet’ on Covid-19 patients will be announced today by Yoga Guru Baba Ramdev and Acharya Balakrishna at Patanjali Yogpeeth Haridwar.

According to Patanjali Yogpeeth, this research on corona tablets is the result of the joint efforts of Patanjali Research Institute Haridwar and National Institute of Medical Science Jaipur. The drug is being manufactured at Divya Pharmacy and Patanjali Ayurved Limited Haridwar. During this time, teams of scientists, researchers, and doctors will also be present.

A few days ago, Acharya Balakrishna claimed that after five months of research at and several rounds of successful trials on mice,  the Patanjali Research Institute has been successful in formulating Ayurvedic medicine for Covid-19.  The clinical case study required for this has been completed, while the clinical control trial is in its final stages.

According to Acharya Balakrishna, the medicine contains Ashwagandha, Giloy, Tulsi, Shvasari juice, and Anu oil. This medicine is authenticated from all major institutions, journals, etc., nationally and internationally, depending on its use, treatment, and effect. This research study on this medicine has also been published in the International Journal of Biomedicine Pharmacotherapy of America.

Currently, three drugs – Ciprimi, Fabiflu, and Covifor – are mainly used to treat corona in the country. Ciprimi and Covifor are generic versions of the antiviral drug remdesivir.

There is a generic form of influenza drug Favipiravir in Fabiflu. All three have received approval recently. If the government approves Patanjali’s ‘Coronil’ tablet to be used in the treatment of corona, it will be the fourth drug.

According to Acharya Balakrishna, Ashwagandha included in Divya Coronil Tablet does not allow Covid-19’s RBD to meet ACE of the human body.  Due to this, healthy cells cannot enter the infected human body.

Giloy also prevents this infection. Tulsi’s compound not only inhibits the rate of increase in coefficients of Covid-19 by attacking RNA-polymerase but also eliminates its frequent intake. On the other hand, the Shvasari juice prevents the formation of thick mucus and reduces the swelling of the lungs by eliminating the mucus formed.

Leave a Reply